Xavier Serra Masia

Title: Xavier Serra Masia: Innovator in Pharmaceutical Chemistry

Introduction

Xavier Serra Masia is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic applications. His work is characterized by a focus on innovative solutions to complex medical challenges.

Latest Patents

Xavier Serra Masia holds a patent for the sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid, which serves as a DHODH inhibitor. This patent encompasses the sodium salt, pharmaceutically acceptable solvates, pharmaceutical combinations, and methods of treatment. This innovation represents a significant advancement in the search for effective treatments.

Career Highlights

Xavier is currently associated with Almirall, S.A., a prominent pharmaceutical company. His role involves research and development aimed at creating new therapeutic options. His expertise in pharmaceutical chemistry has positioned him as a valuable asset in the industry.

Collaborations

Xavier has collaborated with several professionals in his field, including Nuria Garcia Gonzalez and Francesc Carrera Carrera. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Xavier Serra Masia is a distinguished inventor whose work in pharmaceutical chemistry has led to important advancements in medical treatments. His contributions continue to impact the field positively, showcasing the importance of innovation in healthcare.